2MZW | pdb_00002mzw

Staphylococcus aureus FusB:EF-GC3 complex

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC/HMQC	0.250 mM [U-100% 13C; U-100% 15N; partial 2H (grown in D2O with 1H glucose)] EF-GC3, 0.375 mM FusB, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
2	2D 1H-15N TROSY-HSQC	0.250 mM [U-100% 13C; U-100% 15N; partial 2H (grown in D2O with 1H glucose)] EF-GC3, 0.375 mM FusB R19C mutant tagged with MTSL, 20 mM TRIS, 300 mM sodium chloride	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
3	2D 1H-15N TROSY-HSQC	0.250 mM [U-100% 13C; U-100% 15N; partial 2H (grown in D2O with 1H glucose)] EF-GC3, 0.375 mM FusB T26C mutant tagged with MTSL, 20 mM TRIS, 300 mM sodium chloride	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
4	2D 1H-15N TROSY-HSQC	0.250 mM [U-100% 13C; U-100% 15N; partial 2H (grown in D2O with 1H glucose)] EF-GC3, 0.375 mM FusB N150C mutant tagged with MTSL, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT, 6 mg/mL Pf1 phage	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
5	3D HNCA	0.250 mM [U-100% 13C; U-100% 15N; partial 2H (grown in D2O with 1H glucose)] EF-GC3, 0.375 mM FusB, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
6	3D HN(CO)CA	0.250 mM [U-100% 13C; U-100% 15N; partial 2H (grown in D2O with 1H glucose)] EF-GC3, 0.375 mM FusB, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
7	2D 1H-15N HSQC/HMQC	0.30 mM [U-100% 15N, partial 2H (grown in D2O with 1H carbon source), 100 % natural abundance lysine ] EF-GC3, 0.45 mM FusB, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
8	2D 1H-15N HSQC/HMQC	0.30 mM [U-100% 15N, partial 2H (grown in D2O with 1H carbon source), 100 % natural abundance valine ] EF-GC3, 0.45 mM FusB, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
9	2D 1H-15N HSQC/HMQC	0.30 mM [U-100% 15N, partial 2H (grown in D2O with 1H carbon source), 100 % natural abundance phenylalanine ] EF-GC3, 0.45 mM FusB, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
10	2D 1H-15N HSQC/HMQC	0.30 mM [U-100% 15N, partial 2H (grown in D2O with 1H carbon source), 100 % natural abundance alanine ] EF-GC3, 0.45 mM FusB, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
11	2D 1H-15N HSQC/HMQC	0.30 mM [U-100% 15N, partial 2H (grown in D2O with 1H carbon source), 100 % natural abundance asparagine ] EF-GC3, 0.45 mM FusB, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
12	2D 1H-15N HSQC (ARTSY)	0.250 mM [U-100% 13C; U-100% 15N; partial 2H (grown in D2O with 1H glucose)] EF-GC3, 0.375 mM FusB, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT, 6 mg/mL Pf1 phage	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
13	2D 1H-15N HSQC (ARTSY)	0.250 mM [U-100% 13C; U-100% 15N; partial 2H (grown in D2O with 1H glucose)] EF-GC3, 0.375 mM FusB N150C mutant tagged with MTSL, 20 mM TRIS, 300 mM sodium chloride, 5 mM DTT, 6 mg/mL Pf1 phage	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
14	2D 1H-15N HSQC (ARTSY)	0.3 mM FusB [U-100% 15N, partial 2H], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT, 6mg/ml Pf1 phage	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
15	3D TROSY-HNCO	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance lysine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
16	3D TROSY-HNCA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance lysine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
17	3D TROSY-HN(CO)CA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance lysine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
18	3D TROSY-HNCO	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance leucine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
19	3D TROSY-HNCA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance leucine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
20	3D TROSY-HN(CO)CA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance leucine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
21	3D TROSY-HNCO	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance phenylalanine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
22	3D TROSY-HNCA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance phenylalanine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
23	3D TROSY-HN(CO)CA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance phenylalanine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
24	3D TROSY-HNCO	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance valine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
25	3D TROSY-HNCA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance valine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
26	3D TROSY-HN(CO)CA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance valine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
27	3D TROSY-HNCO	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance asparagine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
28	3D TROSY-HNCA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance asparagine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
29	3D TROSY-HN(CO)CA	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance asparagine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150
30	2D 1H-15N HSQC 1H R1 relaxation series (saturation recovery)	0.3 mM FusB [U-100% 15N, partial 2H, 100% natural abundance valine], 0.45 mM EF-GC3, 20 mM TrisHCl, 300 mM NaCl, 5 mM DTT	90% H2O/10% D2O	0.300	8.000	1.000 atm	298.150

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	750
2	Agilent	INOVA	600
3	Varian	INOVA	900

NMR Refinement
Method	Details	Software
simulated annealing	Reorientation of helices in domain IV and domain reorientation as rigid bodies refined to RDCs and solvent PREs, Semi-rigid docking of structures driven by RDCs, ambiguous distance restraints from chemical shift perturbations and distance restraints based on PREs.	X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	1
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNmr Analysis	2.1	CCPN
2	processing	CcpNmr Analysis	2.1	CCPN
3	chemical shift assignment	NMRDraw		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	processing	NMRDraw		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	processing	NMRView	7.9	Johnson, One Moon Scientific
6	data analysis	NMRView	7.9	Johnson, One Moon Scientific
7	structure solution	X-PLOR NIH	2.33.0	Schwieters, Kuszewski, Tjandra and Clore
8	refinement	X-PLOR NIH	2.33.0	Schwieters, Kuszewski, Tjandra and Clore
9	structure solution	HADDOCK	2.1	Alexandre Bonvin
10	docking based on nmr restraints	HADDOCK	2.1	Alexandre Bonvin
11	refinement	HADDOCK	2.1	Alexandre Bonvin